Walgreens Boots Alliance (NASDAQ:WBA) Trading 0.2% Higher

Walgreens Boots Alliance, Inc. (NASDAQ:WBA)’s share price was up 0.2% during mid-day trading on Tuesday . The stock traded as high as $16.00 and last traded at $15.94. Approximately 2,045,716 shares traded hands during trading, a decline of 84% from the average daily volume of 13,033,455 shares. The stock had previously closed at $15.91.

Wall Street Analysts Forecast Growth

WBA has been the subject of several research analyst reports. Truist Financial reissued a “hold” rating and issued a $25.00 target price on shares of Walgreens Boots Alliance in a research report on Monday, April 1st. Bank of America dropped their target price on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating for the company in a research report on Tuesday, March 26th. UBS Group dropped their target price on shares of Walgreens Boots Alliance from $22.00 to $17.00 and set a “neutral” rating for the company in a research report on Monday. Evercore ISI dropped their target price on shares of Walgreens Boots Alliance from $18.00 to $17.00 and set an “in-line” rating for the company in a research report on Monday, June 3rd. Finally, Morgan Stanley dropped their target price on shares of Walgreens Boots Alliance from $16.00 to $13.00 and set an “underweight” rating for the company in a research report on Friday, May 31st. Four analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $23.07.

Walgreens Boots Alliance Price Performance

The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66. The company’s fifty day moving average price is $16.76 and its 200 day moving average price is $20.36. The firm has a market capitalization of $13.51 billion, a price-to-earnings ratio of -2.24, a price-to-earnings-growth ratio of 0.98 and a beta of 0.78.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.82 by $0.38. The firm had revenue of $37.05 billion during the quarter, compared to analyst estimates of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. Walgreens Boots Alliance’s revenue was up 6.3% on a year-over-year basis. During the same period in the previous year, the business posted $1.16 EPS. Equities research analysts expect that Walgreens Boots Alliance, Inc. will post 3.21 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, June 12th. Shareholders of record on Tuesday, May 21st were paid a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 6.39%. The ex-dividend date of this dividend was Monday, May 20th. Walgreens Boots Alliance’s payout ratio is -14.29%.

Insider Buying and Selling at Walgreens Boots Alliance

In other news, CFO Manmohan Mahajan bought 6,000 shares of Walgreens Boots Alliance stock in a transaction on Tuesday, April 2nd. The stock was purchased at an average cost of $19.38 per share, with a total value of $116,280.00. Following the purchase, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, CFO Manmohan Mahajan purchased 6,000 shares of Walgreens Boots Alliance stock in a transaction dated Tuesday, April 2nd. The stock was bought at an average cost of $19.38 per share, with a total value of $116,280.00. Following the purchase, the chief financial officer now owns 166,969 shares in the company, valued at approximately $3,235,859.22. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, Director Inderpal S. Bhandari purchased 3,000 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, April 11th. The stock was bought at an average cost of $18.05 per share, with a total value of $54,150.00. Following the completion of the purchase, the director now owns 3,000 shares in the company, valued at approximately $54,150. The disclosure for this purchase can be found here. 17.40% of the stock is currently owned by company insiders.

Institutional Trading of Walgreens Boots Alliance

A number of institutional investors have recently made changes to their positions in WBA. Highlander Capital Management LLC bought a new stake in shares of Walgreens Boots Alliance in the 4th quarter worth approximately $26,000. Pineridge Advisors LLC bought a new stake in shares of Walgreens Boots Alliance in the 4th quarter worth approximately $26,000. Venturi Wealth Management LLC raised its holdings in shares of Walgreens Boots Alliance by 1,241.8% in the 4th quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 981 shares in the last quarter. Rocky Mountain Advisers LLC bought a new stake in shares of Walgreens Boots Alliance in the 4th quarter worth approximately $30,000. Finally, Quest Partners LLC bought a new stake in shares of Walgreens Boots Alliance in the 4th quarter worth approximately $30,000. 58.59% of the stock is owned by institutional investors and hedge funds.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.